SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stem Cell Research

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Doc Bones7/24/2005 7:56:03 PM
  Read Replies (1) of 495
 
The Future of Stem Cells

Scientific American July 2005 issue

SPECIAL REPORT

A whole section of articles on stem cells, which seem to be available online. - Doc


Letter from the Editors

---

Mother of All Cells

Scientists hope for huge benefits from the surge of research on embryonic stem cells. But it could be a generation before the impact is felt.

Human-Animal Chimeras
Dirty and Dying, but US-Approved?
The Cloning Connection

---

Repair Workers Within

Adult stem cells may escape ethical controversies that beset embryonic stem cells, but their practical clinical value is far more murky.

Patient, Heal Thyself
Making Stem Cells on Demand

---

A Patchwork of Laws

Little consensus exists from country to country about what practices should be allowed, despite several attempts to find agreement.

The Next Frontier: The Courtroom
Engineering Aside the Morality
A World of Approaches to Stem Cells

---

Stem Cells East ... and West

Both China and the UK have created generally favorable regulatory and ethical environments, coupled with strong research bases.

Country Report: China
Country Report: United Kingdom

---

The California Gambit

The Golden State has launched a $3bn wager on stem cell science. Some biologists worry that the initiative could fragment the field.

Scientists Follow the Money
The Ghost of Lysenko

---

Growing Pains for a New Industry

Stem cell startups pursue cutting-edge research with constant worries about cash lifelines.

ES Cell International
Geron
Stem Cell Sciences
ACT Holdings

---

Tough Cell to Investors

Venture capitalists are wary of investing in companies in which risks in the science may not be rewarded by a healthy revenue stream.

---

The Search for Cells That Heal

The creator of Dolly the cloned sheep asks that society look past the controversies to the ultimate payoff.


sciam.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext